1 completed, 1 not yet recruiting. 1 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Not yet recruiting 1 |
| Phase 2 | 1 | Completed 1 |
Follow Acute Undifferentiated Leukemia (AUL): new trials by email Literature Review of Acute Undifferentiated Leukemia (AUL) trials Research Report on Acute Undifferentiated Leukemia (AUL)
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Prophylactic DLI-X for Leukemia Relapse After HCT Exercise Mobilized Prophylactic DLI, Standard Prophylactic DLI - Acute Lymphoid Leukemia, Acute Myeloid Leukemia | Phase 1 | Not yet recruiting | University of Arizona | 180 | 2026-11-30 | 2026-10-22 |
| HLA-Mismatched Unrelated Donor Bone Marrow Transplantation With Post-Transplantation Cyclophosphamide Fludarabine, Cyclophosphamide 14.5 mg/kg/day IV on Days -6, -5, Total Body Irradiation (TBI) 200cGy on Day -1 - Myelodysplastic Syndrome (MDS), Chronic Lymphocytic Leukemia (CLL) | Phase 2 | Completed | Center for International Blood and Marrow Transplant Research | 80 | 2016-12-01 | 2025-08-06 |
Leukemia, Biphenotypic, Acute (2) · Leukemia, Myeloid, Acute (2) · Myelodysplastic Syndromes (2) · Precursor Cell Lymphoblastic Leukemia-Lymphoma (2) · Hematologic Neoplasms (1) · Leukemia, Lymphocytic, Chronic, B-Cell (1) · Leukemia, Myelogenous, Chronic, BCR-ABL Positive (1) · Lymphoma, Non-Hodgkin (1) · Motor Activity (1)
Bone Marrow Diseases (2) · Chronic Disease (2) · Disease Attributes (2) · Hematologic Diseases (2) · Hemic and Lymphatic Diseases (2) · Immune System Diseases (2) · Immunoproliferative Disorders (2) · Leukemia (2) · Leukemia, Lymphoid (2) · Leukemia, Myeloid (2) · Lymphatic Diseases (2) · Lymphoproliferative Disorders (2) · Neoplasms (2) · Neoplasms by Histologic Type (2) · Pathologic Processes (2)
Busulfan (1) · Cyclophosphamide (1) · Filgrastim (1) · Granulocyte Colony-Stimulating Factor (1) · Mycophenolic Acid (1) · Sirolimus (1) · Whole-Body Irradiation (1) · fludarabine (1) · fludarabine phosphate (1)
Center for International Blood and Marrow Transplant Research (1) · University of Arizona (1)
United States (2)
Bronwen E. Shaw, MD, PhD (1) · Emmanuel Katsanis, MD (1)